ABSTRACT
Maxillary sinus grafting is a dependable procedure that has been in use for a long time. However, clinical complications often arise. To prevent complications of maxillary sinus grafting, it is necessary to know the contra-indications, both for general implantation and for maxillary bone grafting. In addition, presence of various complications requires careful consideration of treatment method; therefore, dentists should be familiar with the treatment protocols. Complications can be divided into postoperative, immediate postoperative, and delayed postoperative complications. Particularly for the outpatient, it is necessary to quickly distinguish between treatable cases and cases for which transfer is required. The purpose of this review is to discuss the contra-indications, complications, and treatment options for complications of maxillary sinus graft.
Subject(s)
Humans , Clinical Protocols , Dentists , Maxilla , Maxillary Sinus , Methods , Outpatients , Postoperative Complications , TransplantsABSTRACT
Maxillary sinus grafting is a dependable procedure that has been in use for a long time. However, clinical complications often arise. To prevent complications of maxillary sinus grafting, it is necessary to know the contra-indications, both for general implantation and for maxillary bone grafting. In addition, presence of various complications requires careful consideration of treatment method; therefore, dentists should be familiar with the treatment protocols. Complications can be divided into postoperative, immediate postoperative, and delayed postoperative complications. Particularly for the outpatient, it is necessary to quickly distinguish between treatable cases and cases for which transfer is required. The purpose of this review is to discuss the contra-indications, complications, and treatment options for complications of maxillary sinus graft.
ABSTRACT
Major histocompatibility complex (MHC) class II molecules, which are recognized for their primary function of presenting an antigen to the T cell receptor, are involved in various signaling pathways in B cell activation. We identified heterogeneous nuclear ribonucleoprotein (hnRNP) A2B1 as an MHC class II molecule-associated protein involved in MHC class II-mediated signal transduction in lipopolysaccharide (LPS)-stimulated 38B9 B cells. Although the function of hnRNP A2B1 in the nucleus is primarily known, the level of hnRNP A2B1 in the cytoplasm was increased in LPS-stimulated 38B9 cells, while it was not detected in the cytoplasm of non-treated 38B9 cells. The silencing of hnRNP A2B1 expression using siRNA disturbed B cell maturation by regulation of mitogen-activated protein kinase signaling, NF-κB activation, and protein kinase B activation. These results suggest that hnRNP A2B1 is associated with MHC class II molecules and is involved in B cell activation signaling pathways in LPS-stimulated 38B9 cells.
Subject(s)
B-Lymphocytes , Cytoplasm , Heterogeneous-Nuclear Ribonucleoproteins , Major Histocompatibility Complex , Protein Kinases , Proto-Oncogene Proteins c-akt , Receptors, Antigen, T-Cell , RNA, Small Interfering , Signal TransductionABSTRACT
Red ginseng is a well-known alternative medicine with anti-inflammatory activity. It exerts pharmacological effects through the transformation of saponin into metabolites by intestinal microbiota. Given that intestinal microflora vary among individuals, the pharmacological effects of red ginseng likely vary among individuals. In order to produce homogeneously effective red ginseng, we prepared probiotic-fermented red ginseng and evaluated its activity using a dextran sulfate sodium (DSS)-induced colitis model in mice. Initial analysis of intestinal damage indicated that the administration of probiotic-fermented red ginseng significantly decreased the severity of colitis, compared with the control and the activity was higher than that induced by oral administration of ginseng powder or probiotics only. Subsequent analysis of the levels of serum IL-6 and TNF-α, inflammatory biomarkers that are increased at the initiation stage of colitis, were significantly decreased in probiotic-fermented red ginseng-treated groups in comparison to the control group. The levels of inflammatory cytokines and mRNAs for inflammatory factors in colorectal tissues were also significantly decreased in probiotic-fermented red ginseng-treated groups. Collectively, oral administration of probiotic-fermented red ginseng reduced the severity of colitis in a mouse model, suggesting that it can be used as a uniformly effective red ginseng product.
Subject(s)
Animals , Female , Humans , Mice , Administration, Oral , Colitis , Drug Therapy , Allergy and Immunology , Colon , Allergy and Immunology , Dextran Sulfate , Disease Models, Animal , Fermentation , Interleukin-6 , Allergy and Immunology , Lactobacillus plantarum , Metabolism , Mice, Inbred BALB C , Panax , Chemistry , Metabolism , Microbiology , Plant Extracts , Chemistry , Metabolism , Powders , Metabolism , Probiotics , Metabolism , Tumor Necrosis Factor-alpha , Allergy and ImmunologyABSTRACT
Subject(s)
Aggrecans , Alkaline Phosphatase , Bone Regeneration , Cell Culture Techniques , Collagen , Dental Implants , Durapatite , Electrons , Extracellular Matrix Proteins , Gene Expression , Integrin-Binding Sialoprotein , Mesenchymal Stem Cells , Osteocalcin , Real-Time Polymerase Chain Reaction , TitaniumABSTRACT
Subject(s)
Animals , Rats , Bone and Bones , Bone Marrow , Bone Regeneration , Bone Substitutes , Ceramics , Durapatite , Fibrin , Mesenchymal Stem Cells , Microspheres , OsteoblastsABSTRACT
Human bone marrow mesenchymal stem cells are thought to be multipotent cells, which are present in adult marrow, that can replicate as undifferentiated cells and that have the potential to differentiate to lineages of mesenchymal tissues, including bone, cartilage, fat, tenden, muscle, and marrow stroma. Cells that have the characteristics of human mesenchymal stem cells could be isolated from marrow aspirates of human and animals. This study was designed to identify and characterize genes specifically expressed by osteogenic supplements-treated cells by suppression subtractive hybridization(SSH) method. The results were as follows: 1. 2 genes were upregulated genes in osteogenic diffeentiation of hMSCs, which is further proved by Northern blot analysis. 2. IGFBP-2 has been identified playing an important role in bone formation. 3. HF1 was also upregulated during osteogenic differentiation, but its role in bone formation is not clear yet.
Subject(s)
Adult , Animals , Humans , Blotting, Northern , Bone Marrow , Cartilage , Durapatite , Insulin-Like Growth Factor Binding Protein 2 , Mesenchymal Stem Cells , Muscles , OsteogenesisABSTRACT